Q32 Bio (QTTB) Total Debt (2023 - 2026)

Q32 Bio's (QTTB) quarterly Total Debt came in at $8.2 million in Q1 2026, down 35.61% year-on-year from $12.7 million in Q1 2025, and down 15.76% quarter-over-quarter from $9.7 million in Q4 2025.

Q32 Bio (QTTB) Total Debt (2023 - 2026) Analysis & Trends

Q32 Bio's Total Debt history runs 4 years deep, the most recent figure standing at $8.2 million for Q1 2026.

  • On a quarterly basis, Total Debt fell 35.61% year-over-year to $8.2 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 35.61% decrease from a year earlier, with the FY2025 full-year figure at $9.7 million, down 23.28% from the prior year.
  • Total Debt retreated to $8.2 million in Q1 2026 per QTTB's latest filing, from $9.7 million in the prior quarter.
  • Across five years, Total Debt topped out at $12.8 million in Q2 2025 and bottomed at $5.5 million in Q4 2023.
  • The 4-year median for Total Debt is $12.5 million (2024), against an average of $11.0 million.
  • Across the five-year window, Total Debt surged 131.78% in 2024 and plunged 35.61% in 2026, its largest moves.
  • Year by year, Total Debt stood at $5.5 million in 2023, then jumped by 131.78% to $12.7 million in 2024, then fell by 23.28% to $9.7 million in 2025, then decreased by 15.76% to $8.2 million in 2026.
  • Per Business Quant, the three latest QTTB Total Debt figures stand at $8.2 million (Q1 2026), $9.7 million (Q4 2025), and $11.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.96 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 959.06 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Q32 Bio 225.00 Mn 174.25 Mn - 8.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.18 Mn
Dec 31, 2025 9.71 Mn
Sep 30, 2025 11.23 Mn
Jun 30, 2025 12.75 Mn
Mar 31, 2025 12.70 Mn
Dec 31, 2024 12.65 Mn
Sep 30, 2024 12.60 Mn
Jun 30, 2024 12.55 Mn
Mar 31, 2024 12.49 Mn
Dec 31, 2023 5.46 Mn